HIK.L - Hikma Pharmaceuticals PLC

LSE - LSE Delayed price. Currency in GBp
1,794.50
-7.00 (-0.39%)
At close: 4:35PM BST
Stock chart is not supported by your current browser
Previous close1,801.50
Open1,800.00
Bid1,799.00 x 0
Ask1,800.50 x 0
Day's range1,774.50 - 1,807.00
52-week range1,440.00 - 2,089.00
Volume342,267
Avg. volume814,374
Market cap4.347B
Beta (3Y monthly)0.60
PE ratio (TTM)15.40
EPS (TTM)116.50
Earnings date9 Aug 2019
Forward dividend & yield0.40 (2.22%)
Ex-dividend date2019-04-04
1y target est23.92
  • A Spotlight On Hikma Pharmaceuticals PLC's (LON:HIK) Fundamentals
    Simply Wall St.24 days ago

    A Spotlight On Hikma Pharmaceuticals PLC's (LON:HIK) Fundamentals

    Attractive stocks have exceptional fundamentals. In the case of Hikma Pharmaceuticals PLC (LON:HIK), there's is a...

  • An overlooked ex-FTSE 100 dividend stock I’d buy and hold forever
    Fool.co.uklast month

    An overlooked ex-FTSE 100 dividend stock I’d buy and hold forever

    Roland Head explains why he'd buy this former FTSE 100 (INDEXFTSE: UKX) stock, despite its recent demotion to the FTSE 250.

  • Top shares for June 2019
    Fool.co.uk2 months ago

    Top shares for June 2019

    We asked our freelance writers to share their top stock picks for the month.

  • What Kind Of Shareholders Own Hikma Pharmaceuticals PLC (LON:HIK)?
    Simply Wall St.2 months ago

    What Kind Of Shareholders Own Hikma Pharmaceuticals PLC (LON:HIK)?

    Every investor in Hikma Pharmaceuticals PLC (LON:HIK) should be aware of the most powerful shareholder groups...

  • Calculating The Fair Value Of Hikma Pharmaceuticals PLC (LON:HIK)
    Simply Wall St.2 months ago

    Calculating The Fair Value Of Hikma Pharmaceuticals PLC (LON:HIK)

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we will run through one way of estimating the intrinsic value of Hikma Pharmaceuticals PLC (LON...

  • Drug companies that benefit from the war on opioid addiction
    Yahoo Finance4 months ago

    Drug companies that benefit from the war on opioid addiction

    The opioid crisis in the United States is a medical and societal tragedy, but some companies are working to fight addiction.

  • FTSE 100 in seventh heaven as oil, miners gain; Ocado hits life high
    Reuters4 months ago

    FTSE 100 in seventh heaven as oil, miners gain; Ocado hits life high

    The FTSE 100 was up 0.3 percent. The domestically-focused FTSE 250 was up 0.3 percent as investors waited for further Brexit developments with reports that Prime Minister Theresa May would ask the European Union to delay Brexit by at least three months. May's Brexit plans were derailed after the speaker of Britain's parliament said on Monday that her deal could not be voted on again after two thumping defeats unless a different proposal was submitted.

  • Hikma Pharmaceuticals PLC (LON:HIK): What’s The Analyst Consensus Outlook?
    Simply Wall St.4 months ago

    Hikma Pharmaceuticals PLC (LON:HIK): What’s The Analyst Consensus Outlook?

    In December 2018, Hikma Pharmaceuticals PLC (LON:HIK) announced its latest earnings update, which showed that the company turned profitable again after experiencing negative earnings in the previous financial year. Below,Read More...

  • Reuters4 months ago

    Hopes Britain will reject no-deal Brexit buoy Europe, Inditex slides

    European shares jumped on Wednesday as investors bet British lawmakers would vote to reject a disorderly no-deal Brexit, but underwhelming results from Inditex and Adidas kept gains limited. Lawmakers resoundingly voted against Prime Minister Theresa May's amended Brexit deal late on Tuesday, forcing parliament to decide whether to back a no-deal Brexit or seek a last-minute delay to the process. "I think the market can see that today parliament is going to vote against no deal," said Duncan Weldon, cross asset allocation strategist at Legal & General Investment.

  • Reuters4 months ago

    Hikma guides for injectables growth after profit surge

    (Reuters) - Hikma Pharmaceuticals Plc on Wednesday forecast growth in 2019 for its injectable drugs division, as strong demand along with a rebound in its generics business helped it post a 19 percent ...

  • Reuters - UK Focus5 months ago

    FTSE 100 squeezes out gains; ConvaTec drags midcaps

    Britain's main stock index clung on to last session's advance, aided by earnings-driven gains in AstraZeneca and Micro Focus, while medical device maker ConvaTec single-handedly contributed to nearly one-third of the midcap index's dip. The FTSE 100 added 0.1 percent, outperforming its U.S. and European peers, though the FTSE 250 was down 0.4 percent as ConvaTec tanked after reporting what its CEO called "disappointing results".

  • What Investors Should Know About Hikma Pharmaceuticals PLC’s (LON:HIK) Financial Strength
    Simply Wall St.5 months ago

    What Investors Should Know About Hikma Pharmaceuticals PLC’s (LON:HIK) Financial Strength

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Small and large cap stocks are widelyRead More...

  • Simply Wall St.7 months ago

    Read This Before Buying Hikma Pharmaceuticals PLC (LON:HIK) Shares

    We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders Read More...

  • Business Wire8 months ago

    Hikma Demonstrates Support for US Pharmacists and Patient Safety

    Activities at upcoming ASHP conference include sponsorship of important symposium advancing patient safety practices

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes